Contact Us

821 Alexander Rd #204
Princeton, NJ 08540
USA
Company Contact
Leeann Essai
NA Head of Marketing
609-480-9850
leeann.essai@guerbet.com
PR Agency Contact
Meghan Bianco
Taft Communications
meghan@taftcommunication...

More »

News Releases

Guerbet Presents “Prostate Cancer: Where will AI bring Value”

Guerbet (GBT) a global leader in medical imaging, will host an on-demand session in the Innovation Theater during RSNA 2020.

WHERE: Join the meeting through the RSNA virtual booth at www.rsna.org/annual-meeting or at https://www.guerbet.com/en-us/rsna-2020/

WHEN: The program will be available at the above links until April 2021

WHAT: The number of pre-biopsy prostate MRIs has increased considerably in the last decade, yielding a higher number of prostate volumes to analyze and limited number of prostate-expert radiologists. Presented by Dr. Joseph Stancanello, Director of MRI Research, Guerbet Europe, the session will explore how artificial intelligence can increase workflow productivity, raise non-prostate-expert radiologists to the level of expert and share how Guerbet is addressing challenges associated with prostate MRIs with its own dedicated AI research team.

Links will be available until April 2021. To learn more, visit Guerbet at www.rsna.org/annual-meeting or https://www.guerbet.com/en-us/rsna-2020/.

About Guerbet

Guerbet is a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. A pioneer since more than 90 years in the field of contrast media with over 2,800 people globally, Guerbet is continuously innovating with 9% of revenue dedicated to Research & Development and four centers in France, Israel and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €817 million in revenue in 2019. For more information about Guerbet, please visit www.guerbet.com.